Parkinson's disease
Our efforts to address Parkinson’s Disease span not only research groups and faculties, but across international borders.
In some cases partnering with leading overseas organisations, our researchers are investigating everything from human circuits of learning and memory function (synaptic plasticity), to drug repurposing, to tailored medical solutions for individuals.
The work is so diverse, that even within singular projects there are complex combinations of expertise in neuroscience, molecular biology, biochemistry and neuro engineering. And while the impact is global, the footprint within Australia is considerable, including training approximately 85 per cent of deep brain stimulation (DBS) practitioners in the country.
Together, our researchers are combatting a disease which, according to a 2014 report by Parkinson’s Australia, is expected to increase by three times the rate of population growth in coming years.